Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 83015-26-3
Drug Levels and Effects
Summary of Use during Lactation
There is no published experience with atomoxetine during breastfeeding, although reports from the manufacturer found no serious adverse effects in two breastfed infants. If the mother of an older infant requires atomoxetine, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Monitor breastfed infants for excess sedation.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
The author of a review article reported that the manufacturer of atomoxetine (Eli Lilly and Co.) had reports of 2 infants who slept longer than usual after being breastfed by mothers who were taking atomoxetine. Neither of the infants experienced any serious adverse events. Dosages, duration of maternal therapy, infant age and extent of breastfeeding were not provided.[1]
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(ADHD) Amphetamine, Dextroamphetamine, Lisdexamfetamine, Methylphenidate
References
- 1.
- Besag FM. ADHD treatment and pregnancy. Drug Saf. 2014;37:397–408. [PubMed: 24794209]
Substance Identification
Substance Name
Atomoxetine
CAS Registry Number
83015-26-3
Drug Class
Breast Feeding
Lactation
Milk, Human
Adrenergic Uptake Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Atomoxetine - Drugs and Lactation Database (LactMed®)Atomoxetine - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...